<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04076800</url>
  </required_header>
  <id_info>
    <org_study_id>13181</org_study_id>
    <nct_id>NCT04076800</nct_id>
  </id_info>
  <brief_title>Acupuncture and Insulin Doses in Insulin-treated Type 2 Diabetes</brief_title>
  <acronym>ACUDIA</acronym>
  <official_title>Comparison of the Effects of a Standardized Acupuncture Treatment and Sham Acupuncture on Insulin Doses in Insulin-treated Patients With Type 2 Diabetes. A Randomized, Single-blind, Crossover Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Careggi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized, single blinded, cross-over interventional study for evaluating
      the effect of acupuncture versus sham acupuncture in diabetic type 2 patient in insulin
      treatment. Primary end-point of the study is the difference of daily units of insulin between
      treatment and control group; secondary end point are the variation of glycated hemoglobin
      levels, lipids panel (total cholesterol, low density lipoprotein, high density lipoprotein,
      triglycerides), C reactive protein and adiponectin. Variation of epicardial fat thickness
      will be also evaluated by echography. Acupuncture and sham treatment will be administered
      twice a week for 3 months and, after a pause of one month and cross-over between groups for
      other three months. Acupuncture treatment will include use of somatic points (SP6; ST36; KI3;
      CV4; CV12; TE5; LI4; LI11; YinTang; ST28; BL23; BL22; BL20; BL13) and auricular points (most
      tender point on palpation with pressure feelers of 400 g on Stomach, Endocrine, Spleen,
      Kidney, Hungry, Shen man and Pancreas auricular points). Sham acupuncture will be applied
      distal from acupuncture points and areas used for treatment, with shallow insertion and
      without manipulation of the needle (15 needles in total on thorax, abdomen, back, arms and
      legs).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin daily doses</measure>
    <time_frame>12 weeks</time_frame>
    <description>Doses of insulin after standardized titration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>12 weeks</time_frame>
    <description>Variations of HbA1c from beginning to end of each treatment phase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture treatment will include use of somatic points (SP6; ST36; KI3; CV4; CV12; TE5; LI4; LI11; YinTang; ST28; BL23; BL22; BL20; BL13) and auricular points (most tender point on palpation with pressure feelers of 400 gr on Stomach, Endocrine, Spleen, Kidney, Hungry, Shen man and Pancreas auricular points).</description>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_label>Sham acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 2 Diabetes Mellitus

          -  insulin therapy &gt; 20 UI daily for at least 6 months

          -  HbA1c &lt; 69 mmol/mol

        Exclusion Criteria:

          -  Class I Psychiatric illness not adequately treated

          -  Actual pregnancy or breastfeeding, or pregnancy planning.

          -  Corticosteroid treatment

          -  Severe heart failure (NYHA III-IV)

          -  Severe renal failure (pre-dialysis o dialysis),

          -  Severe liver insufficiency (overt cirrhosis)

          -  Severe respiratory failure (oxygen therapy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Silverii, MD</last_name>
    <phone>+393335441169</phone>
    <email>antonio.silverii@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diabetologia AOU Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilaria Dicembrini, MD</last_name>
      <phone>0557946512</phone>
      <email>idicembrini@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 30, 2019</study_first_submitted>
  <study_first_submitted_qc>August 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2019</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria Careggi</investigator_affiliation>
    <investigator_full_name>Edoardo Mannucci</investigator_full_name>
    <investigator_title>Director, Diabetology</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>insulin sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

